PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,110.00
Bid: 12,108.00
Ask: 12,110.00
Change: -56.00 (-0.46%)
Spread: 2.00 (0.017%)
Open: 12,186.00
High: 12,198.00
Low: 12,094.00
Prev. Close: 12,166.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 9-First death with Omicron variant in United Kingdom

Mon, 13th Dec 2021 07:20

* First patient dies with Omicron in UK - Johnson

* New COVID variant doubling every 2-3 days, minister says

* Get a booster as two vaccines not enough, Britain says

* Johnson's poll ratings sink - Ipsos MORI survey

* Omicron will be dominant variant in London in 48 hours
(Adds Javid)

By Guy Faulconbridge and Michael Holden

LONDON, Dec 13 (Reuters) - At least one person has died in
the United Kingdom after contracting the Omicron coronavirus
variant, Prime Minister Boris Johnson said on Monday, the first
publicly confirmed death globally from the swiftly spreading
strain.

Since the first Omicron cases were detected on Nov. 27 in
Britain, Johnson has imposed tougher restrictions and on Sunday
cautioned that the variant could overcome the immune defences of
those inoculated with two shots of vaccines.

Britain gave no details on the death or whether the patient
had been been vaccinated or had underlying health issues. Deaths
from Omicron may have occurred in other countries but none has
been publicly confirmed yet outside Britain.

"Sadly at least one patient has now been confirmed to have
died with Omicron," Johnson told reporters at a vaccination
centre in London.

"So I think the idea that this is somehow a milder version
of the virus - I think that's something we need to set on one
side - and just recognise the sheer pace at which it accelerates
through the population."

Health Secretary Sajid Javid told parliament the variant now
accounted for around 44% of infections in London and would be
the dominant variant in the capital within 48 hours.

Before the death was announced, Britain said 10 people had
been hospitalised with the Omicron variant in various parts of
England. Their ages ranged from 18 to 85 years and most had
received two vaccination doses.

The UK Health Security Agency said Omicron - first detected
in South Africa, Botswana and Hong Kong in late November - can
overcome the immunity of those who have had two shots of
vaccines such as AstraZeneca or Pfizer-BioNTech
.

South Africa's health ministry said it was unable to say
with certainty if any of its COVID-19 deaths were caused by
Omicron as deaths were not broken down by variant.

NEW LOCKDOWNS?

Johnson, who is grappling with a rebellion in his party over
measures to curb Omicron and an outcry over parties at his
Downing Street office during last year's lockdowns, said people
should rush to get booster vaccines to protect "our freedoms and
our way of life".

After COVID-19 was first detected in China in late 2019, he
faced criticism for initially resisting lockdown.

He has also been criticised for overseeing mistakes in
transferring patients into care homes, and for building a costly
test-and-trace system that failed to stop a deadly second wave.

Johnson has repeatedly said that while mistakes were made,
the government was making decisions swiftly in the biggest
public health crisis for generations and that his government was
quick to roll out vaccines.

More than 146,000 people have died from COVID-19 in the
United Kingdom.

Asked if he could rule out tougher restrictions in England
before Christmas, Johnson avoided giving a direct answer.

VACCINE QUEUES

Johnson faces growing anger from libertarians in his party
over stiffer restrictions and sinking poll ratings.

He has also faced criticism over his handling of a sleaze
scandal, the awarding of lucrative COVID contracts, the
refurbishment of his Downing Street flat, and a claim he
intervened to ensure pets were evacuated from Kabul during the
chaotic Western withdrawal in August.

An Ipsos MORI survey for The London Evening Standard
newspaper showed opposition Labour leader Keir Starmer's ranking
was 13 percentage points ahead of Johnson, the first time a
Labour leader had been viewed as a more capable prime minister
since 2008.

It also echoed other polls by showing Labour up three points
on 39% ahead of Johnson's Conservatives, who were down one point
since the last survey in November on 35%.

At St. Thomas' Hospital Vaccination Centre in central
London, a queue of hundreds of people snaked back onto
Westminster Bridge. Reuters journalists also documented queues
across London and in Manchester, northern England.

"The COVID vaccine booking service is currently facing
extremely high demand so is operating a queuing system," the
National Health Service said on Twitter. It suggested trying
again later.

Home testing kits were also unavailable to order.

(Reporting by Guy Faulconbridge and Michael Holden and Hannah
McKay; Editing by Angus MacSwan and Giles Elgood)

More News
11 Apr 2024 08:54

LONDON MARKET OPEN: European markets mixed ahead of ECB decision

(Alliance News) - European equities lacked direction early Thursday morning, ahead of an interest rate decision from the European Central Bank this afternoon.

Read more
11 Apr 2024 07:49

LONDON BRIEFING: Astra promises dividend hike; Darktrace ups guidance

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye the latest interest rate decision from the European Central Bank, a day after a hotter-than-expected US inflation reading.

Read more
11 Apr 2024 07:20

AstraZeneca to hike 2024 dividend by 7%

(Sharecast News) - Biopharma giant AstraZeneca has announced that it will increase its annual dividend by 7%, which the board said demonstrates its confidence in the company's performance and cash generation.

Read more
8 Apr 2024 08:36

TOP NEWS: AstraZeneca hails neurological data for Ultomiris, Soliris

(Alliance News) - AstraZeneca PLC on Monday said long-term data in generalised myasthenia gravis will underscore the "vital role" of its Ultomiris and Soliris antibodies in the treatment landscape.

Read more
8 Apr 2024 07:43

LONDON BRIEFING: Astra hails neurology data; CVS flags cyberattack

(Alliance News) - London's FTSE 100 is called to open a touch higher on Monday, ahead of an interest rate decision in the eurozone and a US inflation reading later in the week.

Read more
8 Apr 2024 07:02

AstraZeneca's Enhurtu cancer gets US green light for adult patients

(Sharecast News) - AstraZeneca and Daiichi Sankyo's Enhertu cancer drug has been approved in the US for adult patients with unresectable or metastatic solid tumours who have received prior systemic treatment and have no satisfactory alternative options.

Read more
8 Apr 2024 06:53

TOP NEWS: AstraZeneca's, Daiichi's Enhertu receives US FDA approval

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Saturday announced that the US Food & Drug Administration has approved their cancer drug conjugate for patients with metastatic HER2-positive solid tumours.

Read more
5 Apr 2024 09:42

AstraZeneca makes "breakthrough" in treating small cell lung cancer

(Alliance News) - AstraZeneca PLC on Friday reported positive results relating to its Imfinzi cancer treatment in phase III trials.

Read more
5 Apr 2024 07:50

LONDON BRIEFING: Shell to book USD600 million first-quarter write-off

(Alliance News) - London's FTSE 100 is called to open lower on Friday, with hawkish remarks from Federal Reserve policymakers and fears of ratcheting Middle East tensions giving investors little to cheer about ahead of the latest US jobs data.

Read more
5 Apr 2024 07:23

AstraZeneca announces positive lung cancer treatment trial results

(Sharecast News) - AstraZeneca announced positive high-level results from a phase three trial demonstrating significant advancements in the treatment of limited-stage small cell lung cancer (LS-SCLC) on Friday.

Read more
4 Apr 2024 13:09

UK shareholder meetings calendar - next 7 days

Friday 5 April 
Faron Pharmaceuticals LtdAGM
VPC Specialty Lending Investments PLCGM re capital return via B share scheme
Monday 8 April 
Premier African Minerals LtdAGM
Tuesday 9 April 
Ethernity Networks LtdEGM re board appointments and option grants
Wednesday 10 April 
Valereum PLCAGM
Wincanton PLCGM re takeover by GXO Logistics Inc
Thursday 11 April 
AstraZeneca PLCAGM
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
3 Apr 2024 22:01

Biden, Senator Bernie Sanders push companies to cut cost of asthma inhalers, prescription drugs

WASHINGTON, April 3 (Reuters) - President Joe Biden hosted a White House event with U.S. Senator Bernie Sanders on Wednesday to tout their fight against high prescription drug prices and push companies to cut the cost of inhalers for asthma sufferers.

Read more
3 Apr 2024 17:22

UK's FTSE 100 pressured by stronger pound; miners climb

FTSE 100 flat, FTSE 250 up 0.2%

*

Read more
3 Apr 2024 11:02

CORRECT: AstraZeneca, Daiichi make US progress with licence approvals

(Correcting the description of extravascular haemolysis' effects on patients with paroxysmal nocturnal haemoglobinuria)

Read more
2 Apr 2024 15:22

London close: Stocks turn red on return from Easter break

(Sharecast News) - UK stocks experienced a downturn by the end of trading on Tuesday, as investors resumed activity following the extended weekend, with initial gains reversed by the close ahead of a week marked by a number of key economic data releases.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.